Q2 2026 results were in line to slightly above expectations, with net sales of $2.2B and adjusted EBITDA of $247M, despite a 1% year-over-year sales decline due to inflation. Strong performance in food and health & beauty offset household and food service softness. Full-year guidance was revised fo…
Q2 2026 results were in line to slightly above expectations, with net sales of $2.2B and adjusted EBITDA of $247M, despite a 1% year-over-year sales decline due to inflation. Strong performance in food and health & beauty offset household and food service softness. Full-year guidance was revised for higher inflation, with cash flow and capital spending targets reaffirmed.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
